While at #AACR26, Moffitt’s Keiran Smalley, PhD (
@LabSmalley
), and Zeynep Eroglu, MD, discuss advances in melanoma research, including tumor-infiltrating lymphocyte therapy and a novel trial using CRISPR-edited TILs.